Ruxolitinib | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Ruxolitinib
U.S. EXCLUSIVITIES

PharmaCompass Sponsored Ads

Contact Supplier

Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ruxolitinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 9 USDMF, 2 EU WC, 1 KDMF, 17 NDC API, 32 Listed Suppliers, $ API Reference Price

40 API Suppliers
9 USDMF
2 EU WC
1 KDMF
17 NDC API
32 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

60 Drugs in Development

60 Drugs in Development

INTERMEDIATES

21 API Suppliers

21 API Suppliers

FINISHED DOSAGE FORMULATIONS

43 FDF Dossiers, 6 FDA Orange Book, 7 Europe, 18 Australia, 3 South Africa, 9 Listed Dossiers

43 FDF Dossiers
6 FDA Orange Book
7 Europe
18 Australia
3 South Africa
9 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 5 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 10 Microlex e.U, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 9 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

1 SPI Pharma
1 DKSH
1 Boai NKY Pharmaceuticals Ltd
10 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
9 BASF
5 DFE Pharma
5 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
17 Kerry
10 Microlex e.U
1 Novo Excipients
3 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
9 Roquette
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
10 Sigachi Industries
1 Ulanqab Kema New Material
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 24 Direct Compression, 16 Disintegrants & Superdisintegrants, 14 Granulation, 13 Thickeners and Stabilizers, 12 Lubricants & Glidants, 12 Co-Processed Excipients, 7 Controlled & Modified Release, 7 Solubilizers, 3 Emulsifying Agents, 3 Coating Systems & Additives, 3 Parenteral, 2 Chewable & Orodispersible Aids, 2 Film Formers & Plasticizers, 2 Taste Masking, 1 Rheology Modifiers, 1 API Stability Enhancers

47 Fillers, Diluents & Binders
24 Direct Compression
16 Disintegrants & Superdisintegrants
14 Granulation
13 Thickeners and Stabilizers
12 Lubricants & Glidants
12 Co-Processed Excipients
7 Controlled & Modified Release
7 Solubilizers
3 Emulsifying Agents
3 Coating Systems & Additives
3 Parenteral
2 Chewable & Orodispersible Aids
2 Film Formers & Plasticizers
2 Taste Masking
1 Rheology Modifiers
1 API Stability Enhancers

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 144 NEWS #PharmaBuzz

5 DATA COMPILATION #PharmaFlow
144 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 7 Finished Drug Prices, 10 Annual Reports

2 US Medicaid Prescriptions
7 Finished Drug Prices
10 Annual Reports

MARKET PLACE

23 APIs, 3 FDF Dossiers

23 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

179 US Patents, 38 US Exclusivities, 8 Health Canada Patents

179 US Patents
38 US Exclusivities
8 Health Canada Patents

$ API Ref.Price (USD/KG) : 27,362 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

38 All

01 38INCYTE CORP

filter Product Reset all filters

38 All

01 38RUXOLITINIB PHOSPHATE

filter Exclusivity Expiration Date Reset all filters

38 All

01 12024-09-21

02 22024-09-22

03 12025-03-21

04 22025-03-22

05 12025-07-18

06 52025-12-19

07 12026-01-18

08 52026-05-24

09 52026-06-19

10 52026-11-24

11 52028-09-22

12 52029-03-22

filter Exclusivity Code Reset all filters

38 All

01 2I-872

02 1I-896

03 5M-285

04 1NP

05 5ODE-238

06 5ODE-373

07 19PED

Granules Ruxolitinib Phosphate

Product Main Page

INCYTE CORP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RUXOLITINIB PHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-285

Exclusivity Expiration Date

2025-12-19

Application Number

202192

Product Number

2

Exclusivity Details

01

INCYTE CORP

RUXOLITINIB PHOSPHATE

2024 ACI Convention

Not Confirmed

INCYTE CORP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

RUXOLITINIB PHOSPHATE

Exclusivity Code : M-285

Exclusivity Expiration Date : 2025-12-19

Application Number : 202192

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

INCYTE CORP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RUXOLITINIB PHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-872

Exclusivity Expiration Date

2024-09-22

Application Number

202192

Product Number

2

Exclusivity Details

02

INCYTE CORP

RUXOLITINIB PHOSPHATE

2024 ACI Convention

Not Confirmed

INCYTE CORP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

RUXOLITINIB PHOSPHATE

Exclusivity Code : I-872

Exclusivity Expiration Date : 2024-09-22

Application Number : 202192

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

INCYTE CORP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RUXOLITINIB PHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-238

Exclusivity Expiration Date

2026-05-24

Application Number

202192

Product Number

2

Exclusivity Details

03

INCYTE CORP

RUXOLITINIB PHOSPHATE

2024 ACI Convention

Not Confirmed

INCYTE CORP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

RUXOLITINIB PHOSPHATE

Exclusivity Code : ODE-238

Exclusivity Expiration Date : 2026-05-24

Application Number : 202192

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

INCYTE CORP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RUXOLITINIB PHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-373

Exclusivity Expiration Date

2028-09-22

Application Number

202192

Product Number

1

Exclusivity Details

04

INCYTE CORP

RUXOLITINIB PHOSPHATE

2024 ACI Convention

Not Confirmed

INCYTE CORP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

RUXOLITINIB PHOSPHATE

Exclusivity Code : ODE-373

Exclusivity Expiration Date : 2028-09-22

Application Number : 202192

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

INCYTE CORP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RUXOLITINIB PHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-285

Exclusivity Expiration Date

2025-12-19

Application Number

202192

Product Number

1

Exclusivity Details

05

INCYTE CORP

RUXOLITINIB PHOSPHATE

2024 ACI Convention

Not Confirmed

INCYTE CORP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

RUXOLITINIB PHOSPHATE

Exclusivity Code : M-285

Exclusivity Expiration Date : 2025-12-19

Application Number : 202192

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

INCYTE CORP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RUXOLITINIB PHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-872

Exclusivity Expiration Date

2024-09-22

Application Number

202192

Product Number

1

Exclusivity Details

06

INCYTE CORP

RUXOLITINIB PHOSPHATE

2024 ACI Convention

Not Confirmed

INCYTE CORP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

RUXOLITINIB PHOSPHATE

Exclusivity Code : I-872

Exclusivity Expiration Date : 2024-09-22

Application Number : 202192

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

INCYTE CORP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RUXOLITINIB PHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-285

Exclusivity Expiration Date

2025-12-19

Application Number

202192

Product Number

3

Exclusivity Details

07

INCYTE CORP

RUXOLITINIB PHOSPHATE

2024 ACI Convention

Not Confirmed

INCYTE CORP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

RUXOLITINIB PHOSPHATE

Exclusivity Code : M-285

Exclusivity Expiration Date : 2025-12-19

Application Number : 202192

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

INCYTE CORP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RUXOLITINIB PHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-238

Exclusivity Expiration Date

2026-05-24

Application Number

202192

Product Number

3

Exclusivity Details

08

INCYTE CORP

RUXOLITINIB PHOSPHATE

2024 ACI Convention

Not Confirmed

INCYTE CORP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

RUXOLITINIB PHOSPHATE

Exclusivity Code : ODE-238

Exclusivity Expiration Date : 2026-05-24

Application Number : 202192

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

INCYTE CORP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RUXOLITINIB PHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-238

Exclusivity Expiration Date

2026-05-24

Application Number

202192

Product Number

1

Exclusivity Details

09

INCYTE CORP

RUXOLITINIB PHOSPHATE

2024 ACI Convention

Not Confirmed

INCYTE CORP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

RUXOLITINIB PHOSPHATE

Exclusivity Code : ODE-238

Exclusivity Expiration Date : 2026-05-24

Application Number : 202192

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

INCYTE CORP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RUXOLITINIB PHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-373

Exclusivity Expiration Date

2028-09-22

Application Number

202192

Product Number

2

Exclusivity Details

10

INCYTE CORP

RUXOLITINIB PHOSPHATE

2024 ACI Convention

Not Confirmed

INCYTE CORP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

RUXOLITINIB PHOSPHATE

Exclusivity Code : ODE-373

Exclusivity Expiration Date : 2028-09-22

Application Number : 202192

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?